Acute Chlamydia pneumoniae infection with heat shock protein 60-related response in patients with acute coronary syndrome

被引:23
作者
Hoshida, S
Nishino, M
Tanouchi, J
Kishimoto, T
Yamada, Y
机构
[1] Osaka Rosai Hosp, Div Cardiol, Sakai, Osaka, Japan
[2] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan
关键词
antibodies; atherosclerosis; inflammation;
D O I
10.1016/j.atherosclerosis.2005.01.054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence has suggested an association between Chlamydia pneumoniae infection and coronary atherosclerosis. A significant association has also been detected between heat shock protein (HSP) 60 antibody and the severity of coronary atherosclerosis. The aim of this study was to define the relationship between instability of ischemic heart disease (IHD) and serum levels of HSP60 and C pneumoniae antibodies. Blood samples for the measurement of serum antibody titers were obtained from 1131 patients with ischemic heart disease (65 9 years, male/female, 828/303) and 127 non-IHD controls with normal coronary arteries (64 9 years; male/female, 60/67) on the day of cardiac catheterization. The serum levels of anti-human HSP60 IgG antibody and anti-chlamydial IgM, but not IgG or IgA, antibody were significantly higher in ACS patients than in stable IHD patients or controls. These results suggest that acute C. pneumoniae infection with HSP60-related immunological responses may contribute to the pathophysiology of acute coronary syndromes. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:109 / 112
页数:4
相关论文
共 27 条
[1]   T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides [J].
Abulafia-Lapid, R ;
Elias, D ;
Raz, I ;
Keren-Zur, Y ;
Atlan, H ;
Cohen, IR .
JOURNAL OF AUTOIMMUNITY, 1999, 12 (02) :121-129
[2]   Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study [J].
Anderson, JL ;
Muhlestein, JB ;
Carlquist, J ;
Allen, A ;
Trehan, S ;
Nielson, C ;
Hall, S ;
Brady, J ;
Egger, M ;
Horne, B ;
Lim, T .
CIRCULATION, 1999, 99 (12) :1540-1547
[3]   Association of serology with the endovascular presence of Chlamydia pneumoniae anti cytomegalovirus in coronary artery and vein graft disease [J].
Bartels, C ;
Maass, M ;
Bein, G ;
Brill, N ;
Bechtel, JFM ;
Leyh, R ;
Sieyers, HH .
CIRCULATION, 2000, 101 (02) :137-141
[4]  
Burian K, 2001, CIRCULATION, V103, P1503
[5]   DETECTION OF CHLAMYDIA-PNEUMONIAE TWAR IN HUMAN CORONARY ATHERECTOMY TISSUES [J].
CAMPBELL, LA ;
OBRIEN, ER ;
CAPPUCCIO, AL ;
KUO, CC ;
WANG, SP ;
STEWART, D ;
PATTON, DL ;
CUMMINGS, PK ;
GRAYSTON, JT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :585-588
[6]   Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial [J].
Cercek, B ;
Shah, PK ;
Noc, M ;
Zahger, D ;
Zeymer, U ;
Matetzky, S ;
Maurer, G ;
Mahrer, P .
LANCET, 2003, 361 (9360) :809-813
[7]   Chlamydia pneumoniae IgA titres and coronary heart disease -: Prospective study and meta-analysis [J].
Danesh, J ;
Whincup, P ;
Lewington, S ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Wong, YK ;
Zhou, X ;
Ward, M .
EUROPEAN HEART JOURNAL, 2002, 23 (05) :371-375
[8]   Chlamydia pneumoniae IgG titres and coronary heart disease:: prospective study and meta-analysis [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Wong, YK ;
Bernardes-Silva, M ;
Ward, M .
BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :208-212
[9]   Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis [J].
Ericson, K ;
Saldeen, TGP ;
Lindquist, O ;
Påhlson, C ;
Mehta, JL .
CIRCULATION, 2000, 101 (22) :2568-2571
[10]  
Gieffers J, 2001, CIRCULATION, V103, P351